NCT05347329View on ClinicalTrials.gov

A Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus

NACompletedINTERVENTIONAL

Enrollment

197

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions

Erectile Dysfunction

Interventions

DIETARY_SUPPLEMENT

Tongkat Ali Maca Plus

Tongkat Ali and Maca (Tongkat Ali: powdered extract 200 mg (from roots of Eurycoma longifolia Jack) + Maca: powdered extract 100 mg (from dried tuberous root of Lepidium meyenii).

Trial Locations (1)

Unknown

Faculty of Medicine, Menoufia University/ Egypt, Shibīn al Kawm

All Listed Sponsors

lead

Natural Wellness Egypt

INDUSTRY

NCT05347329 - A Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus | Biotech Hunter | Biotech Hunter